Literature DB >> 22948536

A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles.

Liang-Ting Lin1, Shih-Hwa Chiou, Te-Wei Lee, Ren-Shyan Liu, Jeng-Jong Hwang, Chih-Hsien Chang, Hsin-I Ma, Yi-Jang Lee.   

Abstract

PURPOSE: Glioblastoma multiforme (GBM) is the most malignant brain tumor with the characteristics of highly infiltrative growth and recurrent rate. In this study, we used animal imaging and molecular expressive profiles to investigate the characteristics of the primary tumor (GBM-3) cells and recurrent tumor (S1R1) cells from different GBM patients. PROCEDURES: Bioluminescent imaging and 3T magnetic resonance imaging (MRI) were used for assessing the orthotopical tumor development of GBM cells harboring a polycistronic reporter gene system. Western blot analysis and quantitative polymerase chain reaction were used to compare the molecular expressive profiles of two types of GBM cells.
RESULTS: S1R1 cells exhibited apparent invasive ability compared to GBM-3 cells using in vitro invasion assay. In vivo bioluminescent imaging showed that intracranial tumors are formed by both types of GBM cells, but the bioluminescent signal was also detected in the lumbar region at late-stage tumor formed by S1R1 cells. The MRI showed that intracranial tumors formed by S1R1 cells were highly infiltrative compared to that formed by GBM-3 cells. Additionally, these two GBM types expressed different patterns of molecules associated with tumor development. Moreover, the suppressive effects of interleukine-23 (IL-23) on xenograft tumors formed by both GBM types were detected using bioluminescent imaging.
CONCLUSION: The current data suggest that the in vivo growth behaviors and therapeutic responses of the primary and recurrent human GBMs were comparable using the reporter gene imaging, and different molecular expressive profiles exist between these two GBM types.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22948536     DOI: 10.1007/s11307-012-0591-x

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  45 in total

Review 1.  Noninvasive cell-tracking methods.

Authors:  Moritz F Kircher; Sanjiv S Gambhir; Jan Grimm
Journal:  Nat Rev Clin Oncol       Date:  2011-09-27       Impact factor: 66.675

Review 2.  Matrix metalloproteinases and their biological function in human gliomas.

Authors:  S K Chintala; J C Tonn; J S Rao
Journal:  Int J Dev Neurosci       Date:  1999 Aug-Oct       Impact factor: 2.457

3.  Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model.

Authors:  Feng-Yi Yang; Guan-Liang Lin; Shih-Cheng Horng; Tien-Kuei Chang; Shih-Yen Wu; Tai-Tong Wong; Hsin-Ell Wang
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2011-05       Impact factor: 2.725

4.  Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

Authors:  J Boström; J M Cobbers; M Wolter; G Tabatabai; R G Weber; P Lichter; V P Collins; G Reifenberger
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

5.  Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.

Authors:  Jelena Stojic; Carsten Hagemann; Stefanie Haas; Christian Herbold; Siglinde Kühnel; Stefanie Gerngras; Wolfgang Roggendorf; Klaus Roosen; Giles Hamilton Vince
Journal:  Neurosci Res       Date:  2007-09-29       Impact factor: 3.304

6.  Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures.

Authors:  Carsten Hagemann; Jelena Anacker; Stefanie Haas; Daniela Riesner; Beate Schömig; Ralf-Ingo Ernestus; Giles H Vince
Journal:  BMC Res Notes       Date:  2010-11-10

7.  Supratentorial glioblastoma with spinal cord intramedullary metastasis.

Authors:  M G Hamilton; B I Tranmer; N A Hagen
Journal:  Can J Neurol Sci       Date:  1993-02       Impact factor: 2.104

8.  In vivo imaging, tracking, and targeting of cancer stem cells.

Authors:  Erina Vlashi; Kwanghee Kim; Chann Lagadec; Lorenza Della Donna; John Tyson McDonald; Mansoureh Eghbali; James W Sayre; Encrico Stefani; William McBride; Frank Pajonk
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

9.  Application of therapeutic insonation to malignant glioma cells and facilitation by echo-contrast microbubbles of levovist.

Authors:  Yoshinobu Manome; Hiroshi Furuhata; Akifumi Hashimoto; Naotake Funamizu; Rie Suzuki; Sho Ishizawa; Nobutake Akiyama; Toshiaki Kobayashi; Michiko Watanabe
Journal:  Anticancer Res       Date:  2009-01       Impact factor: 2.480

10.  Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster.

Authors:  Luca Sessa; Achim Breiling; Giovanni Lavorgna; Laura Silvestri; Giorgio Casari; Valerio Orlando
Journal:  RNA       Date:  2006-12-21       Impact factor: 4.942

View more
  4 in total

1.  Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.

Authors:  Liang-Ting Lin; Chun-Yuan Chang; Chih-Hsien Chang; Hsin-Ell Wang; Shih-Hwa Chiou; Ren-Shyan Liu; Te-Wei Lee; Yi-Jang Lee
Journal:  Oncotarget       Date:  2016-10-04

2.  Arsenic trioxide-mediated suppression of miR-182-5p is associated with potent anti-oxidant effects through up-regulation of SESN2.

Authors:  Liang-Ting Lin; Shin-Yi Liu; Jyh-Der Leu; Chun-Yuan Chang; Shih-Hwa Chiou; Te-Chang Lee; Yi-Jang Lee
Journal:  Oncotarget       Date:  2018-03-23

3.  Strategic Decoy Peptides Interfere with MSI1/AGO2 Interaction to Elicit Tumor Suppression Effects.

Authors:  Yi-Ping Yang; Andy Chi-Lung Lee; Liang-Ting Lin; Yi-Wei Chen; Pin-I Huang; Hsin-I Ma; Yi-Chen Chen; Wen-Liang Lo; Yuan-Tzu Lan; Wen-Liang Fang; Chien-Ying Wang; Yung-Yang Liu; Po-Kuei Hsu; Wen-Chang Lin; Chung-Pin Li; Ming-Teh Chen; Chian-Shiu Chien; Mong-Lien Wang
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

4.  Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.

Authors:  Hsiao-Yun Chen; Liang-Ting Lin; Mong-Lien Wang; Shu-Hsien Lee; Ming-Long Tsai; Chi-Chang Tsai; Wei-Hsiu Liu; Tzu-Chien Chen; Yi-Ping Yang; Yi-Yen Lee; Yuh-Lih Chang; Pin-I Huang; Yi-Wei Chen; Wen-Liang Lo; Shih-Hwa Chiou; Ming-Teh Chen
Journal:  Oncotarget       Date:  2016-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.